CSL Ltd.

CSL Ltd. CSL

Dividend Summary

The next CSL Ltd. dividend is expected to go ex in 3 months and to be paid in 4 months.
The previous CSL Ltd. dividend was 175.8299999999999c and it went ex 3 months ago and it was paid 2 months ago.
There are typically 2 dividends per year (excluding specials), and the dividend cover is approximately 2.0.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid Forecast
Type Final Interim
Per share 175.83c (118c) Sign Up Required
Declaration date 17 Aug 2022 (Wed) 15 Feb 2023 (Wed)
Ex-div date 06 Sep 2022 (Tue) 06 Mar 2023 (Mon)
Pay date 05 Oct 2022 (Wed) 05 Apr 2023 (Wed)

Enter the number of CSL Ltd. shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
We have not made any dividend predictions for CSL Ltd.
Dividend Yield Today
1.1%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for CSL Ltd.
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Forecast Final 18 Aug 2027 31 Aug 2027 29 Sep 2027 USD Sign up
Forecast Interim 17 Feb 2027 01 Mar 2027 31 Mar 2027 USD Sign up
Forecast Final 12 Aug 2026 01 Sep 2026 30 Sep 2026 USD Sign up
Forecast Interim 11 Feb 2026 02 Mar 2026 01 Apr 2026 USD Sign up
Forecast Final 13 Aug 2025 02 Sep 2025 01 Oct 2025 USD Sign up
Forecast Interim 12 Feb 2025 03 Mar 2025 02 Apr 2025 USD Sign up
Forecast Final 14 Aug 2024 03 Sep 2024 02 Oct 2024 USD Sign up
Forecast Interim 14 Feb 2024 04 Mar 2024 03 Apr 2024 USD Sign up
Forecast Final 16 Aug 2023 05 Sep 2023 04 Oct 2023 USD Sign up
Forecast Interim 15 Feb 2023 06 Mar 2023 05 Apr 2023 USD Sign up
Paid Final 17 Aug 2022 06 Sep 2022 05 Oct 2022 USD 118c
Paid Interim 16 Feb 2022 07 Mar 2022 06 Apr 2022 USD 104c
Paid Final 18 Aug 2021 02 Sep 2021 30 Sep 2021 USD 118c
Paid Interim 18 Feb 2021 04 Mar 2021 01 Apr 2021 USD 104c
Paid Final 19 Aug 2020 10 Sep 2020 09 Oct 2020 USD 107c
Paid Interim 12 Feb 2020 11 Mar 2020 09 Apr 2020 USD 95c
Paid Final 14 Aug 2019 10 Sep 2019 11 Oct 2019 USD 100c
Paid Interim 13 Feb 2019 13 Mar 2019 12 Apr 2019 USD 85c
Paid Final 15 Aug 2018 11 Sep 2018 12 Oct 2018 USD 93c
Paid Interim 14 Feb 2018 14 Mar 2018 13 Apr 2018 USD 79c
Paid Final 16 Aug 2017 12 Sep 2017 13 Oct 2017 USD 72c
Paid Interim 15 Feb 2017 15 Mar 2017 13 Apr 2017 USD 64c
Paid Final 17 Aug 2016 13 Sep 2016 07 Oct 2016 USD 68c
Paid Interim 16 Feb 2016 23 Mar 2016 15 Apr 2016 USD 58c
Paid Final 12 Aug 2015 07 Sep 2015 02 Oct 2015 USD 66c
Paid Interim 11 Feb 2015 16 Mar 2015 10 Apr 2015 USD 58c
Paid Final 08 Sep 2014 03 Oct 2014 USD 60c
Paid Interim 12 Feb 2014 05 Mar 2014 04 Apr 2014 USD 53c
Paid Final 09 Sep 2013 04 Oct 2013 USD 52c
Paid Interim 05 Mar 2013 05 Apr 2013 AUD 48.66c
Paid Final 17 Sep 2012 12 Oct 2012 AUD 47c
Paid Interim 14 Mar 2012 13 Apr 2012 AUD 36c
Year Amount Change
2006 0.0c
2007 0.0c
0%
2008 0.0c
0%
2009 0.0c
0%
2010 0.0c
0%
2011 0.0c
0%
2012 83.0c
100%
2013 105.64c
27.3%
2014 123.73c
17.1%
2015 164.38c
32.9%
2016 170.14c
3.5%
2017 175.31c
3.0%
2018 228.32c
30.2%
2019 265.77c
16.4%
2020 294.09c
10.7%
2021 293.88c
-0.1%
2022 Sign Up Required
2023 Sign Up Required
2024 Sign Up Required
2025 Sign Up Required
2026 Sign Up Required
2027 Sign Up Required

CSL Ltd. Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
1.1%
Optimized Yield
Sign Up Required
52 Week High
1.5% on 03 November 2022
52 Week Low
1.3% on 24 November 2022
Next Ex-Div-Date Countdown
Sign Up Required

About CSL Ltd.

CSL Limited (CSL) is a biotechnology company engaged in developing and delivering biotherapies and influenza vaccines that treat people with serious diseases and chronic medical conditions. CSL provides a portfolio of life saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Its segments include CSL Behring and Seqirus. CSL Behring manufactures, markets, and develops plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, receives license and royalty income from the commercialization of intellectual property and undertakes the administrative and corporate function required to support the Company. Seqirus manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.

Sector
Pharmaceuticals & Biotechnology
Country
Australia
Share Price
AU$299.72 (yesterday's closing price)
Shares in Issue
482 million
Market Cap
AU$144.5bn
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
2.0
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
1
Market Indices
none
No articles found